Alamar Biosciences, Inc. Statistics
Alamar Biosciences, Inc. (ALMR) Stock Statistics & Valuation Metrics
Total Valuation
Alamar Biosciences, Inc. has a market cap or net worth of $1.95B. The enterprise value is $1.68B.
- Market Cap
- $1.95B
- Enterprise Value
- $1.68B
Share Statistics
Alamar Biosciences, Inc. has 69,481,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 69,481,650
- Owned by Insiders
- 10.30%
- Owned by Institutions
- 11.37%
Financial Efficiency
Alamar Biosciences, Inc.’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is -26.47%.
- Return on Equity (ROE)
- 0.19
- Return on Assets (ROA)
- -0.21
- Return on Invested Capital (ROIC)
- -26.47%
- Return on Capital Employed (ROCE)
- -0.27
- Revenue Per Employee
- 334.28K
- Profits Per Employee
- -134.32K
- Employee Count
- 222
- Asset Turnover
- 0.53
- Inventory Turnover
- 0.84
Valuation Ratios
The current PE Ratio of Alamar Biosciences, Inc. is -44.22. Alamar Biosciences, Inc.’s PEG ratio is 0.54.
- PE Ratio
- -44.22
- PS Ratio
- 19.37
- PB Ratio
- 7.25
- Price to FCF
- -32.22
- Price to Operating Cash Flow
- -36.12
- PEG Ratio
- 0.54
Income Statement
In the last 12 months, Alamar Biosciences, Inc. had revenue of 74.21M and earned -29.82M in profits. Earnings per share was -0.45.
- Revenue
- 74.21M
- Gross Profit
- 41.70M
- Operating Income
- -31.33M
- Pretax Income
- -29.15M
- Net Income
- -29.82M
- EBITDA
- -24.89M
- Earnings Per Share (EPS)
- -0.45
Cash Flow
In the last 12 months, operating cash flow was -60.92M and capital expenditures -7.66M, giving a free cash flow of -68.58M billion.
- Operating Cash Flow
- -60.92M
- Free Cash Flow
- -68.58M
- Free Cash Flow per Share
- -0.99
Dividends & Yields
Alamar Biosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.15%
- Earnings Yield
- -2.54%
Stock Price Statistics
- Beta
- -0.29
- 52-Week Price Change
- 27.50%
- 50-Day Moving Average
- 30.14
- 200-Day Moving Average
- 26.99
- Relative Strength Index (RSI)
- 46.28
- Average Volume (3m)
- 611.68K
Important Dates
Alamar Biosciences, Inc. upcoming earnings date is ―, After Close (Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Alamar Biosciences, Inc. as a current ratio of 3.99, with Debt / Equity ratio of -26.09%
- Current Ratio
- 3.99
- Quick Ratio
- 2.37
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.46
- Interest Coverage Ratio
- -78.14
Taxes
In the past 12 months, Alamar Biosciences, Inc. has paid 665.00K in taxes.
- Income Tax
- 665.00K
- Effective Tax Rate
- -0.02
Enterprise Valuation
Alamar Biosciences, Inc. EV to EBITDA ratio is -41.84, with an EV/FCF ratio of -30.58.
- EV to Sales
- 18.39
- EV to EBITDA
- -41.84
- EV to Free Cash Flow
- -30.58
- EV to Operating Cash Flow
- -34.42
Balance Sheet
Alamar Biosciences, Inc. has $226.59M in cash and marketable securities with $42.35M in debt, giving a net cash position of $184.24M billion.
- Cash & Marketable Securities
- $226.59M
- Total Debt
- $42.35M
- Net Cash
- $184.24M
- Net Cash Per Share
- $2.65
- Tangible Book Value Per Share
- $4.37
Margins
Gross margin is 59.32%, with operating margin of -42.08%, and net profit margin of -48.23%.
- Gross Margin
- 59.32%
- Operating Margin
- -42.08%
- Pretax Margin
- -47.62%
- Net Profit Margin
- -48.23%
- EBITDA Margin
- -43.94%
- EBIT Margin
- -46.90%
Analyst Forecast
The average price target for Alamar Biosciences, Inc. is $34.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $34.00
- Price Target Upside
- 21.21% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 7
- AI Score
- ―
